Evidence map›Paper›PMID 32147086›Full record

ArticleJournal of hepatology2020

High prevalence of hepatitis C infection among multidrug-resistant tuberculosis patients.

Kwonjune J Seung, Molly F Franke, Catherine Hewison, Helena Huerga, Uzma Khan, Carole D Mitnick, end TB Study Group

Erratum issued Registry-linked trialAbstract readLetterComment
PubMed Publisher
In one paragraph

Article in Journal of hepatology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to trial NCT03259269 (endTB), which is not on this map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03259269 completednot on this map

endTB (Expand New Drugs for TB) Observational Study: Treatment of MDR-TB With Regimens Containing Bedaquiline or Delamanid

TypeobservationalSponsorPartners in HealthRan2015 to 2019Enrolled2,804ConditionsTuberculosis, Multidrug-ResistantArmsThis is a non-intervention observational study
3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Observational
  2. Article
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Kwonjune J SeungPartners In Health, Boston, USA; Department of Global Health and Social Medicine, Harvard Medical School, Boston, USA; Division of Global Health Equity, Brigham and Women's Hospital, Boston, USA. Electronic address: kjseung@pih.org.
Molly F FrankePartners In Health, Boston, USA; Department of Global Health and Social Medicine, Harvard Medical School, Boston, USA.
Catherine HewisonMedical Department, Médecins Sans Frontières, Paris, France.
Helena HuergaField Epidemiology Department, Epicentre, Paris, France.
Uzma KhanInteractive Research and Development, Dubai, United Arab Emirates.
Carole D MitnickPartners In Health, Boston, USA; Department of Global Health and Social Medicine, Harvard Medical School, Boston, USA; Division of Global Health Equity, Brigham and Women's Hospital, Boston, USA.
end TB Study Group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Hepatitis CHIV InfectionsPharmaceutical PreparationsTuberculosis, Multidrug-ResistantHumansPrevalencePharmaceutical PreparationsHepatitis CMultidrug-resistant tuberculosisTuberculosis

Identifiers

PMID32147086

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.